Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds LU1224032463
102.05
EUR
-0.60
EUR
-0.58
%
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Dokumente | Sharpe Ratio | |
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Anlageziel Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds
The main objective of this Sub-Fund is to profit from increasing share prices in the pharmaceutical sector worldwide. The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.
Stammdaten
| Valor | |
| ISIN | LU1224032463 |
| Fondsgesellschaft | J. Lamarck Asset Management |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | EUR |
| Mindestanlage | 4’674.46 |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager |
Aktuelle Daten
| Fondsnote | - |
| Aktueller Rücknahmepreis | 102.05 |
| Fondsvolumen | 7’259’054.36EUR |
| Total Expense Ratio (TER) | 1.30% |
Gebühren
| Verwaltungsgebühr | - |
| Depotbankgebühr | - |
| Rücknahmegebühr | 0.00 % |
| Ausgabeaufschlag | 3.00 % |
Basisdaten
| Auflagedatum | 17.07.2015 |
| Depotbank | Quintet Private Bank (Europe) S.A. |
| Zahlstelle | Quintet Private Bank (Europe) S.A. |
| Domizil | Luxembourg |
| Geschäftsjahr | 31.12.2025 |
Performancedaten
| Veränderung Vortag | -0.60 EUR (-0.58 %) |